TARSUS PHARMACEUTICALS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$19M
Free Cash Flow↑+18116.7% +$13M
$13M
Investing Cash Flow
$49M
Financing Cash Flow↓-21.0% -$615K
$2M
Capex↑+8730.6% +$6M
$6M
Stock-Based Comp↑+93.4% +$7M
$14M
Debt Issued
$0
D&A↑+5.2% +$10K
$202K
SBC Allocated Expense↑+93.4% +$7M
$14M